chrisvoncsefalvay/vaers-outcomes huggingface dataset:
no period since May 5 (2 weeks after last COVID shot); weight gain; last period now 59 days ago; no period since May 5 (2 weeks after last COVID shot); weight gain; last period now 59 days ago; This is a spontaneous report from a contactable consumer or other non-healthcare professional.  A 43-years-old female non-pregnant patient (not pregnant at the time of vaccination) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot Number: ew0153), via an unspecified route of administration, administered in Right arm on 17Apr2021 (43-year-old at the time of vaccination) as dose 2, single for covid-19 immunisation. Medical history included migraine from an unknown date and unknown if ongoing. Concomitant medication included erenumab aooe (AIMOVIG) taken for migraine, start and stop date were not reported and multivitamins. Historical vaccine included the patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot Number: en6203), via an unspecified route of administration on 28Mar2021 (43-year-old at the time of vaccination) as dose 1, single for covid-19 immunisation. On 05May2021 the patient experienced no period since may 5 (2 weeks after last covid shot); weight gain; last period now 59 days ago. The outcome of events was not resolved.   Follow-Up : Follow-up attempts are completed. No further information is expected.
D68.9 COAGULOPATHY, UNSPECIFIED TYPE 11/30/2022 UTERINE MASS I82.402 ACUTE DVT OF LEFT LEG, UNSPECIFIED VEIN 12/5/2022 UTERINE MASS I95.9 HYPOTENSION 12/5/2022 UTERINE MASS J96.00 ACUTE RESPIRATORY FAILURE 12/5/2022 UTERINE MASS
11/04/2022 09:30PM after I got out of the shower, I noticed I had a soft ball size lump on the right leg. It was red, and hot. It was where the vein doctor gave me the injection at for a problem I was having. I knew what she will say so decided to go to the ER. At the ER they did ultrasound and every was normal. I had a follow up with my vein doctor today 11/08/2022 at 09:45AM to check for the procedure that was done 2 weeks ago. The vein doctor said that the medication that is used in the anti-inflammatory drug that she used in the injection was also used in the vaccine which caused it to flare up where the procedure was done.
Redness (red circle)  itching and swelling around vaccine site after one week of infection.
pt recvd vax 3JAN91 & initially there was a mild inject site rxn which then progressed to a 1 cm atrophy (1/2 CM deep) in lt outer upper thigh; may require some surgery for repair;
itchy; red; swollen; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itchy), VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE SWELLING (swollen) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced VACCINATION SITE PRURITUS (itchy), VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE SWELLING (swollen). At the time of the report, VACCINATION SITE PRURITUS (itchy), VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE SWELLING (swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information and concomitant medications are not provided by the reporter.; Sender's Comments: Based on the current available information and temporal association between the use of mRNA-1273 and the onset of the events, a causal relationship cannot be excluded. The reported events are consistent with the product safety profile
The patients Father brought his daughter in for a Covid vaccination on 11/04/2021.  She was given 0.3 ml of the Pfizer Covid Vaccine in the right deltoid, IM. The Father was in the Clinic the next day when he brought his other daughter in to get vaccinated. It was realized at that time that (the daughter that recieved the vaccine)  was 9 yrs old, and was given an incorrect dose. He stated that she woke this am with a headache and sore arm. He gave her Tylenol and she went to school. He also stated that she was doing fine at this time, and would continue to monitor her. This was discussed with RN and the Father. The Father was instructed to contact their local provider of any abnormal signs or symptoms.
This spontaneous report as received from a Medical assistant refers to a 4 years old male patient. The patient was vaccinated with a expired dose of MMR II (lot # 666247/0959Z; exp date: 21-JUL-2012) on 13-AUG-2012. The dose was administered in the patient's left thigh. No adverse experienced had been observed. Additional information has been requested.
body aches, headache, nausea, vomiting, fever, chills, elevated pulse, generalized weakness and dizziness.  Pain to left arm
1) Nausea 10:45. 2) Vomiting 11:00. 3) Rash covering both arms, neck, chest, face 1:00. 4) Headache 2:40.
pt recvd vax APR92 & devel an exacerbation of urticaria or hives; No further details were provided;
Pt vaccinated with DTP/OPV developed cardiorespiratory arrest less than 24 hrs after vax. Pt noted to have abd distension and fussiness along with some respiratory distress prior to arrest. Pt was premature infant w/several med problems.
Information has been received a physician concerning a female who was vaccinated with her first dose of Gardasil. Subsequently, "2 days later" the patient experienced pruritic and maculopapular rash. Unspecified medical attention was sought. The patient recovered from pruritic and maculopapular rash. No product quality complaint was involved. Additional information has been requested.
Patient became light-headed about 5 minutes after injection.  Patient was given water to sip and cool rag for forehead.  Patient became faint and nauseated about 15 minutes later and required to be laid on the floor with feet elevated.  Several attempts were made to assist  patient to sitting over the next hour.  Patient was unable as she immediately became more light-headed and faint.  Patient was evaluated by ER physician after not being able to rise for 1.5 hours.  Patient was then transferred via lift assist and wheelchair for outpatient fluids.
This spontaneous report was received from a registered nurse and refers to an unknown number of patients of unknown age and gender. Patients' pertinent medical history and drug reactions or allergies were not reported. On unknown dates, patients were vaccinated with PROQUAD (lot number L041627 and expiration date 20-APR-2017, lot number L050907 and expiration date 14-JUL-2017, lot number M011664 and expiration date 08-SEP-2017, albumin status therapy type, dose and route of administration were not reported). Concomitant therapy was not reported. The temperature of excursion was 24.1F and the time frame was 5 hours and 41 minutes. There was no previous temperature excursion. No adverse effects were reported. No product quality complaint (PQC) was involved. This is one of the two reports received from the same reporter. Additional information has been received.
After her second shot "I'm starting to get these weird muscle twitches, I had one in my back the other night, I had one in my arm, one in my leg".; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 50 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (dose 1), for COVID-19 immunization. The following information was reported: MUSCLE TWITCHING (non-serious), outcome "not recovered", described as "After her second shot "I'm starting to get these weird muscle twitches, I had one in my back the other night, I had one in my arm, one in my leg".".  Additional information:Patient going to get any vaccine dose until the delta variant, and she honestly felt pressured by society to get it". Caller states that she is a healthy 50-year woman who exercises daily and is under 127 pounds.Patient states that after her second shot "I'm starting to get these weird muscle twitches, I had one in my back the other night, I had one in my arm, one in my leg, they are randomly and sporadically coming and going".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Received Moderna vaccines on 2/17/21, 3/17/21. Tested positive for COVID 19 by PCR on 10/29/21. admitted to Hospital on 10/29/21 w/ SOB, hypoxia, pneumonia. Underlying obesity BMI 54. Started on Remdesivir, dexamethasone. Currently on ventilator
Certified immunization technician opened a vial of pediatric Pfizer vaccine (5 to 11-year-old) and set aside to be drawn-up for an adult booster dose (instead of adult Pfizer vial). Patient inadvertently given 0.3mL of undiluted pediatric Pfizer dose (equivalent to approximately 42mcg versus 30mcg patient should have received).
Severely ill with flu-like symptoms, which subsided for the most part. Now my entire body is breaking out in hives and my eyes are puffy and swollen. This is the first allergic reaction I've ever had and it's terrifying.
Fever; Chills; Body ache; Headache; She had allergic reactions in the area where she took the vaccine and today it turned red, hard and really painful. It was swollen; She had allergic reactions in the area where she took the vaccine and today it turned red, hard and really painful. It was swollen; She had allergic reactions in the area where she took the vaccine and today it turned red, hard and really painful. It was swollen; she had allergy reactions; Some spasm in my neck; This is a spontaneous report from a contactable nurse. A 36-year-old female patient started to receive bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL1283), intramuscular from 05Jan2021 to 05Jan2021 at a single dose for an unspecified indication. Medical history included Hypertension. Concomitant medication included lisinopril. It was reported by the patient that she had side effects of fever, chills, body ache, headache within 24 hours. I received my second dose. She had allergic reactions in the area where she took the vaccine and today it turned red, hard and really painful. It was swollen. She also reported that she had some spasm in my neck and that she had allergy reactions. The patient reported that she took Tylenol as treatment for the events. The outcome of the events was unknown.
CDC reports:2 mo infant developed fever to 100.2 & screaming episode for @2 hrs following immun, recovered same day.
Extreme lethargy (my screaming rambunxious toddler could not even wake her), fever (103 degrees) that lasted until 4/8/2012, green mucousy stool with blood (starting 4/7/2012).  This type of stool still continues intermittently and never started until she received her 2 months vaccines.  This is why I have selected "NO" below in the Patient Recovered (Box 9) area.
Hour after receiving  shot facial numbness for about 5 minutes.  By 2:00 a.m. Friday morning severe migraine like headache, severe joint and muscle aches and soreness, in addition  Friday afternoon vomiting, severe fatigue.  Continued Saturday. By Saturday evening I thought I was on the upswing.  Early Sunday morning it started all over again nausea, headache, felt some numbness facial and head numbness.
This case was reported by a nurse via sales rep and described the occurrence of injection site pain in a 19-year-old female patient received BEXSERO. Previously administered products included BEXSERO (received 1st dose in spring of 2017). On an unknown date, the patient received the 2nd dose of BEXSERO. On an unknown date, less than a year after receiving BEXSERO, the patient experienced injection site pain, injection site erythema and intramuscular formulation administered by other route. On an unknown date, the outcome of the injection site pain and injection site erythema were recovered/resolved and the outcome of the intramuscular formulation administered by other route was unknown. The reporter considered the injection site pain to be related to BEXSERO. It was unknown if the reporter considered the injection site erythema to be related to BEXSERO. Additional details were provided as follows: The nurse reported on behalf of her daughter. The age of vaccination was not reported. In spring of 2017, the patient received 1st dose of BEXSERO. The patient received the 2nd dose of BEXSERO, approximately spaced from her first one. The patient complained about hurting at the injection site, redness at the injection site and tenderness at the injection site. The patient had redness in a large area of her arm and it took about 4 to 5 days to go away. When the reporter looked at the patient's arm, she realized that the patient had received BEXSERO subcutaneously instead of intramuscularly, which led to inappropriate route of vaccination.
I immediately got a headache after the shot and became dizzy several hours later. I went to bed around 9 pm and then woke up around 10 am and was very dizzy and my arm was in severe pain. I had to vomit so I got out of bed and fainted and fell to the floor. I got up again and then fainted and hit the floor. My husband then called 911 and I was transported to the hospital.
Baby was inadvertently given 2 Hep B vaccines and was supposed to recieve a Hib vaccine and wasn't given the Hib, was given an extra dose of Hep B by mistake.
This spontaneous report was received from a nurse and refers to an unspecified patient of unknown age and gender. There was no information regarding the patient's pertinent medical history, drug reactions, allergies or concomitant therapies provided. On 06-FEB-2017, the patient was vaccinated with improperly stored dose of VARIVAX lot # M005974, expiration date 02-FEB-2018 (site, dose and route of administration were not reported). The reason of the call was temperature alarm received via Digital Data Logger. It was reported that the vaccine were exposed to temperature of -14.4 Celsius degrees for 54 minutes before administration. No previous temperature excursion was reported. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information is not expected because all information was obtained.; Sender's Comments: US-009507513-1611USA004113:
I was teaching a class, there was an awful smell in the class, it made my eyes watery. The whole class made it through the evening class, the next morning I could barely move or stay awake. It took all I had to notify the school that I could not come in to teach, I went to a pharmacy clinic and had a Rapid PCR COVID-19 test that came back positive. They said I had a mild case and did not need medication, go home get rest, stay hydrated and call my primary care physician if I needed anything more. I still feel like I have a lingering cough and congestion left over from COVID-19, I cannot yawn, I can stretch and breath but not yawn.
Cough, dyspnea, COVID-19 pneumonia and shortness of breath.
Just have a dry cough all the time.  Drink water and other liquids but it does not seem to help.
Wasn't feeling great after first vaccine; sluggish; This is a spontaneous report from a contactable consumer (patient's wife).  A 47-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot Number: EP7533; Expiration Date: Jul2021), via intramuscular route of administration in Arm Left on 11Apr2021, as 1st dose, single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Patient doesn't take any medication, doesn't drink or do drugs, he was a very healthy person. Patient has nothing and that's what was so strange, Patient was a tall, healthy person. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. It was reported that he wasn't feeling great after first vaccine and sluggish. The patient underwent lab tests and procedures which included covid-19: and influenza: negative on 25May2021. The outcome of the events was unknown.  Information on Lot/Batch number is available; Further information has been requested.
fever started with fever (100-101) on 08/02/05, rash over body started today. Very fussy.
I noticed that I became winded, which is unusual for me.  My heart rate became very low. My toes had started to turn blue and my peripheral neuropathy was worse. I informed my doctor and she ordered an echocardiogram, blood work and ART test. The tests did not reveal anything significant. Over time the blue toes stopped. My heart rate variability is still low, but my breathing is not winded.
received first dose of bnt162b2 (BNT162B2) on 18Dec2020 07:00 at SINGLE DOSE, second dose on 07Jan2021 11:00; injection site pain; swelling, and itching at injection site; itching at injection site; This is a spontaneous report from a contactable Other HCP (patient). The 30-years-old female patient (not pregnant) received first dose of bnt162b2 (BNT162B2) unknown on left arm on 18Dec2020 07:00 at SINGLE DOSE, second dose via unknown on left arm on 07Jan2021 11:00 at SINGLE DOSE, both in hospital for covid-19 immunisation. Medical history included n/a. Concomitant medication included escitalopram oxalate (LEXAPRO), cetirizine hydrochloride (ZYRTEC). The patient did not receive other vaccine in four weeks. No COVID prior or post vaccination. No Known allergies. The patient experienced injection site pain, swelling, and itching at injection site on 07Jan2021 19:00. No treatment received. The outcome of the event  Drug use for unapproved schedule was unknown and for the rest events was not recovered.   Information about lot/batch number has been requested.
My nose was clogged up and I was coughing and I was not feeling well. I went into my doctor and I was told I had viral infection. I was given a Z-PAK, and really just had to wait it out. I struggled with the clogged nose and the cough and using OTC medications to help get over it.
Elevated BP 224/140 Pulse 115 altered mental status Resident approached nurse in hallway saying "I believe i'm having a stroke". Sent to ER Upon EMS arrival, Residents BP: 252/150, HR: 118. Resident unable to lift right arm, stated "her legs were numb", unable to feel pressure when put on right foot. When asked to smile, resident was unable to smile Medical Center reports resident has suffered a CVA
A nurse reported that a female "over 60" tested positive for hepatitis B surface antigen after being vaccinated with hepatitis B vaccine recombinant (Engerix-B) for prophylaxis. The pt's medical history included renal failure (cause not reported) treated with hemodialysis. Concurrent medications were not reported. On 02/26/2003, the pt received a 40-mcg injection of Engerix-B. Nine days later, on 03/07/2003, testing for hepatitis B surface antigen was "positive"; this test had "previously" been "negative". A healthcare professional was consulted regarding the positive test. The reporting nurse considered the event to be possibly related to Engerix-B administration.
Information has been received from a physician concerning a female who in January 2007, was vaccinated with the second dose of rotavirus vaccine. The physician reported that in January 2007, the patient developed diarrhea.  It was unknown if medical attention was sought.  At the time of this report, the outcome was unknown.  Additional information has been requested.
Started developing canker sores and raw spots on oral mucosa, tongue and gums approximately three days after injection, peaking in severity 7/3/2021. Started improving yesterday and nearly cleared up by today. **In retrospect, patient recalls having a sore mouth with no visual lesions after first dose for a few days**
I was really tired.; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (I was really tired.) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 078C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Jul-2021, the patient experienced FATIGUE (I was really tired.). At the time of the report, FATIGUE (I was really tired.) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No Concomitant Medications details were provided.  The  patient  second dose of the Moderna Covid-19 vaccine was due on 08-Aug-2021  No Treatment Medications details were provided.
Pt with circumferential swelling in left upper arm, around area of administration. Within 48 hours, had increase of swelling and erythema. Is recovering.
25 year old female received anthrax vaccine #1 in the right arm and smallpox vaccine in the left arm on 21 Oct 03.  Three days later she developed left clavicle pain, "like a bruise".  She noted a "bump" at the site of the pain.  For approximately three months after receipt of the first anthrax dose, her left shoulder would ache when she ran.  She received the second anthrax vaccine 20 Jan 04.  She had a large, red "bump" and a bruise that did not extend beyond the elbow for approximately 1 ½ to 2 weeks.  The site was warm and tender for the entire 1 ½ to 2 weeks and she did not go to the gym during this time due to the discomfort.  The third dose was given 12 Feb 04.  Within 2 days she was diagnosed with an ear infection and upper respiratory infection.  She also had a local reaction that was not as severe as the previous reaction.  This local reaction was present for about four days.  She currently has no symptoms, but is concerned about continuing the anthrax series and developing other symptoms.
Patient experienced severe dizziness that she said was different than the unsteadiness she typically has. She said the dizziness was over by the next afternoon and she feels fine now.